Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SANTYL vs Silver-containing products for Diabetic Foot Ulcers
NCT02581488Phase 4Completed
- Sponsor
- Smith & Nephew
- Start
- Oct 2015
- Primary completion
- Jan 2017
- Modality
- Therapeutic Enzymes
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial of collagenase in diabetic foot ulcer (DFU) (2 arms), sponsored by Smith & Nephew. Primary endpoint: Mean Percent Change in Ulcer Area From Baseline to the End of the Treatment at 6 weeks. Started Oct 2015; status: completed.
02
Drugs
collagenase
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT02581488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02581488.